![](/img/cover-not-exists.png)
PDB18 COST-EFFECTIVENESS OF ADD-ON PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) THERAPY IN DIABETIC VERSUS NON-DIABETIC PATIENTS WITH DYSLIPIDEMIA: A UK PERSPECTIVE
B Paschen, S Roze, AJ Palmer, WJ Valentine, D Liens, C RenaudinVolume:
8
Year:
2005
Language:
english
DOI:
10.1016/s1098-3015(10)67637-1
File:
PDF, 82 KB
english, 2005